CAMBRIDGE, Mass., Dec. 1, 2019 /PRNewswire/ -- Today, at the
105th RSNA Scientific Assembly and Annual Meeting, IBM
(NYSE: IBM) Watson Health™ highlighted its recent clients
and collaborations for its IBM Watson Health Imaging artificial
intelligence (AI) platform, a leading provider of innovative
artificial intelligence, enterprise imaging and interoperability
solutions available through multiple products and services trusted
by medical professionals worldwide.
IBM Watson Health will be showcasing its suite of solutions
across AI and Machine Learning, Enterprise Imaging, Vendor Neutral
Archive, Image Viewing and Sharing, and PACS at the RSNA
105th RSNA Scientific Assembly and Annual Meeting in
Chicago, IL between December 1 – 6, 2019. The IBM Watson Health
booths are located at the North Hall Level 1 – booth 11332B and North Hall Level 3 — booth 6100.
"We are delighted to announce these collaborations at RSNA
highlighting our advancements in medical imaging globally," said
Anne Le Grand, General Manager,
Imaging, Life Sciences and Oncology, IBM Watson Health. "From
helping clinicians to identify potential missed findings to seeing
a summary view of patient records quickly, our innovative
technologies are at the forefront of Watson Health's mission to
help enable clinicians to more effectively respond to the world's
most pressing health challenges."
Hardin Memorial Health First Provider to Use Patient
Synopsis
In June 2019, Hardin Memorial
Health (HMH) announced it would be the first provider to use IBM
Watson Imaging Patient Synopsis, which provides a summary view of
patients through analytics and extracts insights from patient
records to uncover underlying issues.
"Being the first in the world to 'go live' with IBM Watson
Imaging Patient Synopsis was an enormous milestone for the HMH
team. This tool is already helping to empower HMH to assist
care givers in their treatment of patients through the use of this
revolutionary platform," said Dennis
Johnson, HMH president and CEO. "We look forward to our
ongoing collaboration with IBM Watson Health as we continue to care
for more than 400,000 Central Kentuckians at our facilities."
IBM Watson Health Imaging Clinical Review 3.0 Launches in
UK
On October 30 2019, Clinical
Review 3.0 launched in the UK. The solution is designed to
analyze medical imaging studies and their associated reports to
identify potential missed findings, helping to facilitate more
comprehensive reports, which can potentially lead to higher quality
of care for the patient.
IBM Watson Health Imaging has recently engaged with Fortrus Ltd,
to grow upon the reseller's strong relationship with the UK public
sector, which includes a single supplier outcome-based Managed
Services framework.
Guerbet Signs Exclusive Development Agreement for AI in
Prostate Cancer
Guerbet, a global specialist in contrast agents and solutions
for diagnostic and interventional imaging, also recently signed an
exclusive joint development agreement to develop an artificial
intelligence software solution to support prostate cancer
diagnostics and monitoring, utilizing MR imaging. This deal
extends their earlier collaboration regarding liver
cancer signed in January, 2018.
IBM Imaging AI Marketplace Launched
The IBM Imaging AI Marketplace is a single-source solution
designed to help simplify the complex process of locating,
purchasing, deploying and managing the vast array of AI imaging
applications. The Imaging AI Marketplace is carefully curated and
contains only U.S. Food and Drug Administration (FDA)-cleared
solutions alongside Watson Health developed AI solutions. It
provides a single location for procurement through deployment,
simplifying complex and resource-draining processes, and can be
easily accessed via our iConnect™️Enterprise Archive.
Vendor Partners:
Circle Cardiovascular Imaging
DiA Imaging Analysis Ltd.
MaxQ AI
Quantib BV
VIDA LungPrint
4ways Healthcare Limited Adopts IBM Watson Health
Imaging Merge PACS™
4ways, a fast-growing private tele-radiology
network in the UK that enables UK-based radiologists to
work remotely over a leading technology platform, has committed to
underpin its ambitious growth strategy with IBM Watson Health's
Merge PACS 8.0 platform, upgrading its current platform
to support their business growth. Merge PACS™ is
a workflow platform that is designed to help simplify
physicians' reading activities and can empower IT leaders with
advanced control of the flow of studies throughout the
enterprise.
"We're committed to constantly investing in and upgrading our IT
provision to be able to offer our clients and partners the very
best service. That means working with the best tech providers in
our space. We've used Merge solutions successfully for many
years so continuing with IBM Watson Health imaging solutions was a
natural next step. Merge PACS is designed to handle high-enterprise
imaging volumes, perform in diverse reading environments, and helps
us to scale our delivery of care," said Ajay Chadha, CEO, 4ways.
About IBM Watson Health
Watson Health is a business unit of IBM that is dedicated to the
development and implementation of AI and data-driven technologies
to advance health. Watson Health technologies are tackling a wide
range of the world's biggest healthcare challenges including
cancer, diabetes, drug discovery and more. Learn more
at ibm.com/watson/health.
About Fortrus
Fortrus operates an outcome based
managed service procurement framework for digital transformation
across the UK public sector, which has a value of £10 billion.
Fortrus is a leading solutions development company focused on user
experience software design, providing managed service
contracts to a network of NHS customers.
About Guerbet
Guerbet is a pioneer in the
contrast-agent field, with more than 90 years' experience, and is a
leader in medical imaging worldwide. It offers a comprehensive
range of pharmaceutical products, medical devices and services for
diagnostic and interventional imaging, to improve the diagnosis and
treatment of patients. With 8% of revenue dedicated to R&D and
more than 200 employees distributed amongst its four centers in
France, Israel and the
United States, Guerbet is a substantial investor in research
and innovation. Guerbet (GBT) is listed on Euronext Paris (segment
B – mid caps) and generated €790 million in revenue in 2018.
For more information about Guerbet, please
visit www.guerbet.com
About Hardin Memorial Health
HMH is an integrated
system of providers and facilities serving approximately 400,000
residents in 10 Central Kentucky
counties (Hardin, LaRue, Meade,
Breckinridge, Grayson, Nelson, Hart,
Bullitt, Green and Taylor). The 300-bed hospital in Elizabethtown, Kentucky includes 270 acute
care, 15 psychiatric and 15 skilled nursing beds. Additionally, HMH
includes 50+ outpatient facilities across the service area
including a Cancer Care Center and Outpatient Surgical Center.
There are over 445 physicians and advanced practice clinicians in
over 40 specialties and primary care including Hospitalists
available 24/7, Emergency and Urgent Care; Cancer, Cardiac, Rehab
and Therapy Services; Medical and Surgical Services; Pulmonary
Care, Diagnostic Imaging, Ear, Nose and Throat, Plastic and
Reconstructive Surgery, Obstetrics including a Level II Neonatal
Intensive Care Unit (NICU) and Pediatrics. With 2,700 employees and
an active volunteer corps of 140, Hardin Memorial Hospital is the
third largest employer in Hardin
County.
About 4ways
4ways is a UK-based market leader in the
provision of high-quality remote radiology reporting services. As a
trusted partner to the NHS and private healthcare clients, 4ways
offers flexible and responsive services in four areas; urgent
reporting, routine reporting, advanced super-specialist reporting
and clinical audit. Since 2005, clients have relied on 4ways to
provide high-quality, cost-effective radiology diagnoses
contributing to better clinical decision making and improved
patient outcomes.
The types of reporting that 4ways covers includes; critical and
urgent services with double-read life threat and polytrauma
reporting, routine reporting of general, neurological, paediatric,
muscular-skeletal, GIT/UIT, gynae, prostate and vascular reporting.
4ways is the market leader in offering advanced remote
super-specialist reporting that includes CT-colonography, nuclear
medicine, PET-CT, breast MRI, mammography, cardiac CT and cardiac
MRI.
IBM Media Contact:
Rachel Ford Hutman
Rachel.Hutman@ibm.com
+1 (301) 801-5540
View original content to download
multimedia:http://www.prnewswire.com/news-releases/ibm-watson-health-demonstrates-global-imaging-market-momentum-300966932.html
SOURCE IBM Watson Health